427 related articles for article (PubMed ID: 32187834)
1. SARS-CoV-2, the Virus that Causes COVID-19: Cytometry and the New Challenge for Global Health.
Cossarizza A; De Biasi S; Guaraldi G; Girardis M; Mussini C;
Cytometry A; 2020 Apr; 97(4):340-343. PubMed ID: 32187834
[No Abstract] [Full Text] [Related]
2. Lymphopenia during the COVID-19 infection: What it shows and what can be learned.
Tavakolpour S; Rakhshandehroo T; Wei EX; Rashidian M
Immunol Lett; 2020 Sep; 225():31-32. PubMed ID: 32569607
[No Abstract] [Full Text] [Related]
3. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
Le Bert N; Tan AT; Kunasegaran K; Tham CYL; Hafezi M; Chia A; Chng MHY; Lin M; Tan N; Linster M; Chia WN; Chen MI; Wang LF; Ooi EE; Kalimuddin S; Tambyah PA; Low JG; Tan YJ; Bertoletti A
Nature; 2020 Aug; 584(7821):457-462. PubMed ID: 32668444
[TBL] [Abstract][Full Text] [Related]
4. T cells found in coronavirus patients 'bode well' for long-term immunity.
Leslie M
Science; 2020 May; 368(6493):809-810. PubMed ID: 32439770
[No Abstract] [Full Text] [Related]
5. New view on older adults with COVID-19: comments on "SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes".
Xu G; Ye M; Zhao J; Liu F; Ma W
Geroscience; 2020 Oct; 42(5):1225-1227. PubMed ID: 32710258
[No Abstract] [Full Text] [Related]
6. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
7. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory Cell Infiltration of Adrenals in COVID-19.
Zinserling VA; Semenova NY; Markov AG; Rybalchenko OV; Wang J; Rodionov RN; Bornstein SR
Horm Metab Res; 2020 Sep; 52(9):639-641. PubMed ID: 32629518
[TBL] [Abstract][Full Text] [Related]
10. The phenotypic changes of γδ T cells in COVID-19 patients.
Lei L; Qian H; Yang X; Zhang X; Zhang D; Dai T; Guo R; Shi L; Cheng Y; Zhang B; Zhou X; Hu J; Guo Y
J Cell Mol Med; 2020 Oct; 24(19):11603-11606. PubMed ID: 32864865
[TBL] [Abstract][Full Text] [Related]
11. The paramount importance of serological surveys of SARS-CoV-2 infection and immunity.
Goudsmit J
Eur J Epidemiol; 2020 Apr; 35(4):331-333. PubMed ID: 32318914
[No Abstract] [Full Text] [Related]
12. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
[TBL] [Abstract][Full Text] [Related]
13. Monocyte volumetric parameters and lymph index are increased in SARS-CoV-2 infection.
Zeng X; Xing H; Wei Y; Tang Z; Lu X; Wang Z; Liu Y; Xu L; Hu L; Wang L; Xu D
Int J Lab Hematol; 2020 Dec; 42(6):e266-e269. PubMed ID: 32981233
[No Abstract] [Full Text] [Related]
14. A Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes.
Qiu L; Jiao R; Zhang A; Chen X; Ning Q; Fang F; Zeng F; Tian N; Zhang Y; Huang Y; Sun Z; Dhuromsingh M; Li H; Li Y; Xu R; Chen Y; Luo X
Pediatr Infect Dis J; 2020 Jul; 39(7):e87-e90. PubMed ID: 32379199
[TBL] [Abstract][Full Text] [Related]
15. Positive Anti-SSA/Ro Antibody in a Woman with SARS-CoV-2 Infection Using Immunophenotyping: A Case Report.
Huang PI; Lin TC; Liu FC; Ho YJ; Lu JW; Lin TY
Medicina (Kaunas); 2020 Oct; 56(10):. PubMed ID: 33028028
[TBL] [Abstract][Full Text] [Related]
16. Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic?
Laxminarayan R; John TJ
Indian Pediatr; 2020 Jun; 57(6):505-507. PubMed ID: 32376793
[No Abstract] [Full Text] [Related]
17. Herd Immunity: Understanding COVID-19.
Randolph HE; Barreiro LB
Immunity; 2020 May; 52(5):737-741. PubMed ID: 32433946
[TBL] [Abstract][Full Text] [Related]
18. The COVID-19 pandemic.
Ciotti M; Ciccozzi M; Terrinoni A; Jiang WC; Wang CB; Bernardini S
Crit Rev Clin Lab Sci; 2020 Sep; 57(6):365-388. PubMed ID: 32645276
[TBL] [Abstract][Full Text] [Related]
19. Peripheral Blood Examination Findings in SARS-CoV-2 Infection.
Nazarullah A; Liang C; Villarreal A; Higgins RA; Mais DD
Am J Clin Pathol; 2020 Aug; 154(3):319-329. PubMed ID: 32756872
[TBL] [Abstract][Full Text] [Related]
20. Immune status could be associated with severity in COVID-19 patients.
Liu C; Yang J; Wang W; Mi Y; Tang Y; Zheng P
Rev Assoc Med Bras (1992); 2020; 66Suppl 2(Suppl 2):13-16. PubMed ID: 32965348
[No Abstract] [Full Text] [Related]
[Next] [New Search]
